EMBC241220C20000
- 1.00
- -0.30-23.08%
Embecta Newsroom
Is It Time To Consider Buying Embecta Corp. (NASDAQ:EMBC)?
This Dick's Sporting Goods Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Embecta Price Target Raised to $20 From $17 at BofA
Express News | Embecta Corp : Btig Raises to Buy From Neutral
BTIG Upgrades Embecta to Buy, Announces $26 Price Target
Embecta Analyst Ratings
Morgan Stanley Maintains Embecta(EMBC.US) With Sell Rating, Maintains Target Price $13
BTIG Upgrades Embecta(EMBC.US) to Buy Rating, Announces Target Price $26
Embecta Corporation: Discontinued Patch Pump Program and Financial Shortfalls Prompt Sell Rating
Embecta Corporation's Strategic Shifts and Revenue Outlook Prompt 'Sell' Rating
Market Might Still Lack Some Conviction On Embecta Corp. (NASDAQ:EMBC) Even After 35% Share Price Boost
Biggest Stock Movers Wednesday: ADSK, HPQ, URBN, EMBC, AMBA, IREN, and More
Embecta Corporation Reports Strong 2024 Financial Results
Embecta Corp. Declares Quarterly Cash Dividend of $0.15 Per Share
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Poseida PSTX Merger Agreement Roche RHHBY; Embecta EMBC Earnings
Consumer Stocks Enter the Limelight With Black Friday and Cyber Monday Around the Corner
Embecta Corp. (EMBC) Q4 2024 Earnings Call Transcript Summary
Becton Dickinson Spinoff Embecta Stops Insulin Patch Pump Program, Plans Restructuring, Stock Jumps
Embecta Shares Surge 26% on Solid Guidance, Restructuring Plan